tirzepatide launch Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute Tirzepatide (Month 1) 2.5mg |

Chronic rhinosinusitis with nasal polyps causes inflammation of the nasal and sinus passages with nasal polyps, leading to symptoms like facial pain/pressure, loss of smell (hyposmia/anosmia), nasal drainage and nasal obstruction

66 Notably, semaglutide and tirzepatide (GLP-1RA + GIPR agonist) have been approved for chronic weight management in non-diabetic obese patients due to its significant weight-reducing efficacy

Pfizer provides update on oral GLP-1 receptor agonist danuglipron [press release]

International Journal of Molecular Sciences, 25 (8), 4346

Cardiovascular-liver-metabolic health: recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach

The complexity of the immuneendocrine axis is further highlighted by the unexpected finding that mice overexpressing TNF are protected from high-fat diet-induced insulin resistance (207)